10x Genomics, Inc.
10x Genomics, Inc.（TXG）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · TXG · 截至 2025年9月30日
股东结构概览
324
机构持有人数
▲ 21 vs Q2
$1.44B
机构持仓总市值
▲ $15.98M vs Q2
126.96M
总流通股
freeFloat 90.65%
123.06M
13F 申报持股数
▲ 254,767 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
TXG 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC laboratory analytical instruments | 13.27M | 10.73% | 10.73% | $155.18B | Nov 7, 2025 | ▲ 834.3K |
ARK INVESTMENT MANAGEMENT LLC laboratory analytical instruments | 11.89M | 9.61% | 9.61% | $138.96B | Nov 12, 2025 | ▼ 2.00M |
BLACKROCK, INC. laboratory analytical instruments | 9.46M | 7.64% | 7.64% | $110.59B | Nov 12, 2025 | ▲ 25.6K |
FMR LLC laboratory analytical instruments | 8.46M | 6.83% | 6.83% | $98.87B | Nov 13, 2025 | ▼ 538.4K |
MILLENNIUM MANAGEMENT LLC laboratory analytical instruments | 5.44M | 4.39% | 4.39% | $63.57B | Nov 14, 2025 | ▲ 2.55M |
SUMITOMO MITSUI TRUST HOLDINGS, INC. laboratory analytical instruments | 5.38M | 4.35% | 4.35% | $62.91B | Oct 27, 2025 | ▼ 636.7K |
NIKKO ASSET MANAGEMENT AMERICAS, INC. laboratory analytical instruments | 5.38M | 4.34% | 4.34% | $62.86B | Nov 12, 2025 | ▼ 632.8K |
WELLINGTON MANAGEMENT GROUP LLP laboratory analytical instruments | 4.29M | 3.46% | 3.46% | $50.10B | Nov 14, 2025 | ▲ 2.39M |
QUANTINNO CAPITAL MANAGEMENT LP laboratory analytical instruments | 3.49M | 2.82% | 2.82% | $40.83B | Nov 14, 2025 | ▲ 1.26M |
BANK OF AMERICA CORP /DE/ laboratory analytical instruments | 3.41M | 2.76% | 2.76% | $39.90B | Feb 3, 2026 | ▲ 389.8K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
23
增持
+15.23M 股2
新建仓
首次建仓22
减持
−10.34M 股0
清仓
完全退出净股数变化（前50家）
+4.89M
+15.23M / −10.34M
净新增持仓人
+3
新建 2 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
TXG 内幕交易记录
数据来源：SEC Form 4
近期内部人员以卖出为主。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
0
买入笔数
5
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Saxonov Serge Chief Executive Officer | May 22, 2026 | Sale | 18,175 | $24.44 | $444.2K | 1.15M | Form 4 ↗ |
Saxonov Serge Chief Executive Officer | May 26, 2026 | Sale | 10,718 | $24.71 | $264.8K | 1.14M | Form 4 ↗ |
Hindson Benjamin J. See Remarks | May 22, 2026 | Sale | 11,595 | $24.44 | $283.4K | 502.0K | Form 4 ↗ |
Taich Adam Chief Financial Officer | May 22, 2026 | Sale | 15,098 | $24.44 | $369.0K | 379.9K | Form 4 ↗ |
Saxonov Serge Chief Executive Officer | Apr 14, 2026 | Sale | 5,000 | $24.56 | $122.8K | 1.17M | Form 4 ↗ |
Saxonov Serge Chief Executive Officer | Mar 23, 2026 | Sale | 10,000 | $19.13 | $191.3K | 1.18M | Form 4 ↗ |
Saxonov Serge Chief Executive Officer | Mar 24, 2026 | Sale | 5,000 | $19.52 | $97.6K | 1.17M | Form 4 ↗ |
Saxonov Serge Chief Executive Officer | Mar 2, 2026 | Sale | 14,292 | $22.67 | $324.0K | 1.21M | Form 4 ↗ |
Saxonov Serge Chief Executive Officer | Mar 2, 2026 | Sale | 1,860 | $23.18 | $43.1K | 1.20M | Form 4 ↗ |
Saxonov Serge Chief Executive Officer | Mar 3, 2026 | Gift | 2,750 | — | — | 1.20M | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
10x Genomics, Inc.（TXG）主要由机构投资者持有，机构持股比例约为 96.9%。公司内部人员持股约 9.35%，散户及公众持股约占剩余的 0.00%。
10x Genomics, Inc. 最大机构股东为 VANGUARD GROUP INC，截至 September 30, 2025 持有约 13.27 million 股，占总流通股的 10.73%。
目前共有 324 家机构持有 TXG 股票，合计持仓市值约 $1.44 billion，数据来源为最新 SEC 13F 申报。
常见问题
TXG ownership10x Genomics, Inc.（TXG）主要由机构投资者持有，机构持股约 96.9%。最大股东为 VANGUARD GROUP INC，持股比例 10.73%。内部人员持股约 9.35%。数据来源 SEC Form 13F，截至 September 30, 2025。